Background: A self-assessment rating scale (SAS) is a good tool to assess the fluctuating disease severity and quality of life (QoL) in children with atopic dermatitis (AD). The European Task Force on Atopic Dermatitis created an SAS based on the Scoring Atopic Dermatitis (SCORAD) index, called the Patient-Oriented SCORAD (PO-SCORAD). Objective: The aim of our study was to measure the correlation between alternative systems such as the Objective SCORAD, the Three-Item Severity (TIS) score and the Objective PO-SCORAD. We also investigated the correlations between the objective severity assessments and QoL. Methods: In a specialized outpatient clinic, an observational prospective study was performed with children ≤16 years with AD. Results: Seventy-five children were included. A good and significant correlation was shown between Objective SCORAD and Objective PO-SCORAD: Spearman's ρ correlation (rs) = 0.63 (p < 0.001). The correlation with QoL was moderate, but still significant (rs = 0.41-0.61, p < 0.001). Conclusion: The Objective PO-SCORAD can be used for the evaluation of fluctuating AD and correlates significantly with the Objective SCORAD and the less time-consuming TIS score.

Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A: Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS One 2012;7:e398033.
De Bruin Weller MS, Knulst AC, Meijer Y, Bruijnzeel-Koomen CA, Pasmans SG: Evaluation of the child with atopic dermatitis. Clin Exp Allergy 2012;42:352-362.
Schuttelaar ML, Vermeulen KM, Coenraads PJ: Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs dermatologist: results of a randomized, controlled trial and a review of international costs. Br J Dermatol 2011;165:600-611.
Beattie PE, Lewis-Jones MS: A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood disease. Br J Dermatol 2006;155:145-151.
Lewis-Jones S: Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006;60:984-992.
McKenna SP, Doward LC: Quality of life of children with atopic dermatitis and their families. Curr Opin Allergy Clin Immunol 2008;8:228-231.
Stalder JF, Taïeb A: Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31.
Schmitt J, Langan S, Williams HC: What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007;120:1389-1398.
Oranje AP, Stalder JF, Taïeb A, Tasset C, de Longueville M: Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. Pediatr Allergy Immunol 1997;8:28-34.
Gelmetti C, Colonna C: The value of SCORAD and beyond. Towards a standardized evaluation of severity? Allergy 2004;59(suppl 78):61-65.
Eichenfield LF: Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy 2004;59(suppl 78):86-92.
Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB: Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol 2007;157:645-648.
Wolkerstorfer A, de Waard van der Spek FB, Glazenburg EJ, Mulder PG, Oranje AP: Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a prescreening tool for studies. Acta Derm Venereol 1999;97:356-359.
Schuttelaar ML, Vermeulen KM, Drukker N, Coenraads PJ: A randomized controlled trial in children with eczema: nurse practitioner vs dermatologist. Br J Dermatol 2010;162:162-170.
Grillo M, Gassner L, Marshman G, Dunn S, Hudson P: Paediatric atopic eczema: the impact of an educational intervention. Pediatr Dermatol 2006;23:428-436.
Ring J, Brockow K, Abeck D: The therapeutic concept of ‘patient management' in atopic eczema. Allergy 1996;51:206-215.
Coleman MT, Newton K: Supporting self-management in patients with chronic illness. Am Fam Physician 2005;72:1503-1510.
Van Os-Medendorp H, Koffijberg H, Eland-de Kok PC, et al: E-health in caring for patients with atopic dermatitis: a randomized controlled trial cost-effectiveness of internet-guided monitoring and self-management training. Br J Dermatol 2012;166:1060-1068.
Vourc'h-Jourdain M, Barbarot S, Taieb A, et al: Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study. Dermatology 2009;218:246-251.
Stalder JF, Barbarot S, Wollenberg A, et al: Patient-oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy 2011;66:1114-1121.
Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A: Clinical validation and guidelines for the SCORAD index: consensus report of the Europe Task Force on Atopic Dermatitis. Dermatology 1997;195:10-19.
Schmitt J, Langan S, Deckert S, et al: Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol 2013;123:1337-1347.
Willemsen MG, van Valburg RW, Dirven-Meijer PC, Oranje AP, van der Wouden JC, Moed H: Determining the severity of atopic dermatitis in children presenting in general practice: an easy and fast method. Dermatol Res Pract 2009;2009:357046.
Charman CR, Venn AJ, Williams H: Measuring atopic eczema severity visually. Arch Dermatol 2005;141:1146-1151.
Holm EA, Wulf HC, Stegmann H, Jemec GB: Life quality assessment among patients with atopic eczema. Br J Dermatol 2006;154:719-725.
Ben-Gashir MA, Seed PT, Hay RJ: Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004;150:284-290.
Van Valburg RW, Willemsen MG, Dirven-Meijer PC, Oranje AP, van der Wouden JC, Moed H: Quality of life measurement and its relationship to disease severity in children with atopic dermatitis in general practice. Acta Derm Venereol 2011;91:147-151.
Monti F, Agostini F, Gobbi F, Neri E, Schianchi S, Arcangeli F: Quality of life measures in Italian children with atopic dermatitis and their families. Ital J Pediatr 2011;37:59.
Williams HC, Burney PG, Pembroke AC, Hay RJ: The UK working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1999;131:406-416.
Objective PO-SCORAD. (accessed June 2012).
Ring J, Alomar A, Bieber T, et al; European Dermatology Forum; European Academy of Dermatology and Venereology; European Task Force on Atopic Dermatitis; European Federation of Allergy; European Society of Pediatric Dermatology; Global Allergy and Asthma European Network: Guidelines for treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2012;26:1176-1193.
Lewis-Jones MS, Finlay AY, Dykes PJ: The infants' dermatitis quality of life index. Br J Dermatol 2001;144:104-110.
Lewis-Jones MS, Finlay AY: The children's dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942-949.
Staab D, von Rueden U, Kehrt R, et al: Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol 2002;13:84-90.
Bodenheimer T, Lorig K, Holman H, Grumbach K: Patient self-management of chronic disease in primary care. JAMA 2002;288:2469-2475.
Holm EA, Esmann S, Jemec GB: Does visible atopic dermatitis affect quality of life more in women than in men? Gend Med 2004;1:125-130.
Schmitt J, Williams HC: Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME1), 24 July 2010, Munich, Germany. Br J Dermatol 2010;163:1166-1168.
Salek MS, Jung S, Brincat-Ruffini LA, et al: Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012. Br J Dermatol 2013;169:734-759.
Basra MK, Gada V, Ungaro S, Finlay AY, Salek SM: Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application. Br J Dermatol 2013;169:760-768.
Chernyshov PV: Gender differences in health-related and family quality of life in young children with atopic dermatitis. Int J Dermatol 2012;51:290-294.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.